Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...

We all want our homes to look nice. What we all can’t have, though, is a new sofa every season, a renovation every time kitchen trends shift, or always-spotless countertops. For most people, life ...

Serial entrepreneur Jan Pacas – who founded popular pet care marketplace Mad Paws and HR software company Flare before establishing biotech All G – says the breakthrough will dramatically close the ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Forecasts of job disruption wrought by AI vary dramatically. The rapid adoption of artificial intelligence tools has unleashed doomsday predictions of a broken career ladder and massive job losses.

Where can one find a multi-Grammy Award-winning mix engineer, one of only 15 women in history to play for the Harlem Globetrotters, an Emmy Award-winning producer, an internationally recognized singer ...

The possible creation of a shareable, governmentwide database of Americans’ personal information would be a “surveillance nightmare,” 10 House and Senate Democrats wrote in a letter to the tech ...

On May 30, 2025, The New York Times published an article titled "Trump Taps Palantir to Compile Data on Americans," detailing a supposed combined effort between the U.S. federal government and the ...

Community driven content discussing all aspects of software development from DevOps to design patterns. If you plan to do database development with Java and MySQL, the first thing you’ll need to do is ...

The Trump administration is collecting data on all Americans, and they are enlisting the data analysis company Palantir to do it. The New York Times reports that President Trump has enlisted the firm, ...

Computational pathology to predict docetaxel benefit in patients with metastatic hormone-sensitive prostate cancer from the CHAARTED trial (ECOG-ACRIN E3805). This is an ASCO Meeting Abstract from the ...